Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo have?
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo has 20 citations in the OpenAlex counts ScholarIQ stores.
When was Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo published?
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo has 2019 year in the ScholarIQ index.
What is the open-access status of Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo?
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo has gold oa status in the ScholarIQ index.
What is the DOI of Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo?
The DOI for Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo is on the source record.
What is the PMID of Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo?
The PMID for Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo is on the source record.
What is the OpenAlex record for Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo?
The OpenAlex for Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo is on the source record.